FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Life Sciences Enterprise Capital Monitor – Europe 12/2021”.
The Monitor is a month-to-month revealed overview of enterprise capital developments within the European Life Sciences sector.
As of the top of December 2021 we establish the next present VC developments in Europe:
- In 2021, general Life Sciences funding has reached EUR 13,874m
- High 5 Offers exceed EUR 200m every, largest transaction amounted to EUR 497m in CMR Surgical Ltd. (United Kingdom)
- Novo Holdings (Denmark) dominates the High 5 Traders (by deal quantity), adopted by BlackRock (USA) and Constancy Administration & Analysis (USA)
- The MedTech sector acquired 32% of the entire funding quantity (-5% factors in comparison with the earlier month)
- Central Nervous System dominates as the highest indication of the Biotechnology sector
To entry the total report, please click on right here.
By Dr. Mathias Schott and Sebastian Sommer